Board of Directors

Mr. Collin McKinney - BSEE, is Vice-President and co-founder of Tracera. Collin is an electronics design engineer with 25+ years experience in development of radioactivity monitoring devices, cyclotron target systems, radiochemistry systems, and analytical chemistry instrumentation. Collin has developed new solid-state radiation detector technology, automation devices, and computer control algorithms that are enabling technologies for Tracera. He has held engineering and engineering management positions at Texas Instruments, Inc., Duke University Medical Center, the University of North Carolina, and was previously Vice President of Engineering at Biosystems Technologies, Inc. He serves on the board of directors of Threshold Corporation, Petaluma, CA.

Dr. Tim DeGrado – Ph.D., is scientific founder of Tracera, director of cyclotron and radiopharmaceutical chemistry at the Brigham and Women's Hospital in Boston. Dr. DeGrado received his Ph.D. degree in Medical Physics in 1988 from the University of Wisconsin-Madison, with Post-Doctoral work in radiochemistry at the Research Center in Juelich, Germany. His first academic years were spent at Duke University, working on the development of fluorine-18 labeled PET radiopharmaceuticals. His research has focused on the potential of small molecules labeled with PET isotopes as indicators of biochemical status in tissues. Dr. DeGrado is an active member in the Society of Nuclear Medicine, Society for Radiopharmaceutical Sciences, Academy of Molecular Imaging, and Society of Molecular Imaging. He has authored over 60 scientific papers and numerous abstracts and book chapters. He has 3 patents on fluorine-18 labeled PET radiopharmaceuticals.